Charles River Laboratories International (CRL) Total Current Liabilities (2009 - 2025)

Charles River Laboratories International (CRL) has reported Total Current Liabilities for 17 consecutive years, with $1.1 billion the latest figure, recorded in Q4 2025.

• In Q4 2025, Total Current Liabilities rose 12.7% year-over-year to $1.1 billion; the TTM figure through Dec 2025 stood at $1.1 billion (up 12.7% YoY), while the FY2025 annual figure was $1.1 billion, up 12.7% from the prior year.
• Total Current Liabilities came in at $1.1 billion for Q4 2025 at Charles River Laboratories International, roughly flat from $1.1 billion in the prior quarter.
• The five-year high for Total Current Liabilities was $1.1 billion in Q3 2025, with the low at $803.4 million in Q1 2021.
• Average Total Current Liabilities over 5 years is $1.0 billion, with a median of $1.0 billion recorded in 2023.
• Across the five-year window, Total Current Liabilities gained 27.7% in 2021 and slipped 5.96% in 2024, its largest moves.
• Year by year, Total Current Liabilities stood at $1.0 billion in 2021, then climbed by 5.65% to $1.1 billion in 2022, then slipped by 3.34% to $1.1 billion in 2023, then slipped by 5.78% to $994.1 million in 2024, then advanced by 12.7% to $1.1 billion in 2025.
• According to Business Quant data, Total Current Liabilities over the past three periods registered $1.1 billion, $1.1 billion, and $1.1 billion for Q4 2025, Q3 2025, and Q2 2025 respectively.